Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-000609

CHIEF FINANCIAL OFFICER sold 12,000 shares at $20.00 ($240,000)

  • CHIEF FINANCIAL OFFICER acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2024-01-03 Option exercise 10b5-1 +12,000 $8.83 $105,960 27,632 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2024-01-03 Sale 10b5-1 −12,000 $20.00 $240,000 15,632 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2024-01-03 Option exercise · Share Option 10b5-1 −12,000 0 D
Open-market sales · 12,000 sh · avg $20.00 · $240,000
Loading xslF345X05/form4-01042024_040113.xml…